UnitedHealth Group Incorporated (UNH) Director Sells $2,875,650.00 in Stock
UnitedHealth Group Incorporated (NYSE:UNH) Director Richard T. Burke sold 15,000 shares of the company’s stock in a transaction dated Monday, August 21st. The shares were sold at an average price of $191.71, for a total transaction of $2,875,650.00. Following the completion of the transaction, the director now directly owns 1,818,898 shares of the company’s stock, valued at $348,700,935.58. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.
Shares of UnitedHealth Group Incorporated (NYSE:UNH) traded up 1.44% during midday trading on Tuesday, hitting $194.79. 2,021,757 shares of the company’s stock traded hands. UnitedHealth Group Incorporated has a 1-year low of $132.39 and a 1-year high of $196.04. The company has a 50 day moving average price of $190.68 and a 200 day moving average price of $176.29. The firm has a market capitalization of $188.33 billion, a price-to-earnings ratio of 23.40 and a beta of 0.64.
UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share for the quarter, beating the consensus estimate of $2.38 by $0.08. The business had revenue of $50.05 billion for the quarter, compared to analyst estimates of $49.97 billion. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. The firm’s revenue was up 7.7% on a year-over-year basis. During the same period in the previous year, the business earned $1.96 EPS. Equities analysts anticipate that UnitedHealth Group Incorporated will post $9.87 earnings per share for the current year.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 19th. Shareholders of record on Friday, September 8th will be given a $0.75 dividend. The ex-dividend date of this dividend is Thursday, September 7th. This represents a $3.00 dividend on an annualized basis and a yield of 1.54%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 35.13%.
A number of research firms have weighed in on UNH. Jefferies Group LLC reissued a “buy” rating and issued a $215.00 price objective on shares of UnitedHealth Group in a research report on Friday. Morgan Stanley upped their price objective on shares of UnitedHealth Group from $210.00 to $215.00 and gave the company an “overweight” rating in a research report on Thursday, August 17th. Cowen and Company reissued an “outperform” rating and issued a $220.00 price objective (up from $175.00) on shares of UnitedHealth Group in a research report on Friday, August 11th. Zacks Investment Research raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $215.00 price objective for the company in a research report on Tuesday, August 1st. Finally, Oppenheimer Holdings, Inc. reissued an “outperform” rating and issued a $205.00 price objective (up from $203.00) on shares of UnitedHealth Group in a research report on Friday, July 21st. One analyst has rated the stock with a hold rating and twenty-four have issued a buy rating to the company. The company presently has an average rating of “Buy” and an average price target of $203.41.
Institutional investors have recently added to or reduced their stakes in the stock. Patriot Financial Group Insurance Agency LLC raised its position in UnitedHealth Group by 1,722.9% in the first quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock worth $106,000 after buying an additional 603 shares during the period. Blue Chip Partners Inc. purchased a new position in UnitedHealth Group during the second quarter worth approximately $110,000. Cribstone Capital Management LLC raised its position in UnitedHealth Group by 22.6% in the first quarter. Cribstone Capital Management LLC now owns 678 shares of the healthcare conglomerate’s stock worth $113,000 after buying an additional 125 shares during the period. Kings Point Capital Management raised its position in UnitedHealth Group by 27.9% in the first quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock worth $113,000 after buying an additional 150 shares during the period. Finally, Bruderman Asset Management LLC purchased a new position in UnitedHealth Group during the second quarter worth approximately $114,000. Hedge funds and other institutional investors own 86.21% of the company’s stock.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.